VA Office of Research and Development
research.va.govTotal trials
1,720
Active
463
Phase 3
83
Total enrollment
3,618,700
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 40 of 116 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Empagliflozin | — | — | — | — | 4 | ||
| Methylphenidate | — | — | — | — | 4 | ||
| Acetazolamide | — | — | — | 3 | |||
| Suvorexant | — | — | — | — | — | 2 | |
| pimavanserin | — | — | — | — | 2 | ||
| Finasteride | — | — | — | — | 3 | ||
| Quetiapine | — | — | — | — | — | 2 | |
| Atomoxetine | — | — | — | — | — | 1 | |
| Clopidogrel treatment | — | — | — | — | — | 1 | |
| Aspirin treatment | — | — | — | — | — | 1 | |
| Medication optimization | — | — | — | — | — | 1 | |
| Apixaban | — | — | — | — | — | 1 | |
| Rivaroxaban | — | — | — | — | — | 1 | |
| Trazodone + PAP therapy | — | — | — | — | — | 1 | |
| Oxygen + PAP therapy | — | — | — | — | — | 1 | |
| Pentoxifylline | — | — | — | — | — | 1 | |
| Acetazolamide + supplemental oxygen + PAP therapy | — | — | — | — | — | 1 | |
| Zolpidem + PAP therapy | — | — | — | — | — | 1 | |
| Buspirone + PAP therapy | — | — | — | — | — | 1 | |
| Sublingual buprenorphine with naloxone | — | — | — | — | — | 1 | |
| Injectable subcutaneous buprenorphine | — | — | — | — | — | 1 | |
| mirabegron | — | — | — | — | — | 1 | |
| Teriparatide or human parathyroid hormone (PTH) 1-34 | — | — | — | — | — | 1 | |
| Cinacalcet | — | — | — | — | — | 1 | |
| Motivation-Phase Varenicline | — | — | — | — | — | 1 | |
| Motivation-Phase Nicotine Mini-Lozenge | — | — | — | — | — | 1 | |
| Cessation-Phase Combination Nicotine Replacement Therapy | — | — | — | — | — | 1 | |
| Cessation-Phase Varenicline | — | — | — | — | — | 1 | |
| Lorazepam 1 mg | — | — | — | — | — | 1 | |
| Metformin XR | — | — | — | — | — | 1 | |
| Colchicine | — | — | — | — | — | 1 | |
| Prazosin | — | — | — | — | — | 2 | |
| Carvedilol | — | — | — | — | 2 | ||
| Full Dose MDMA | — | — | — | — | — | 1 | |
| Active Placebo Dose MDMA | — | — | — | — | — | 1 | |
| Goserelin, Histrelin, Leuprolide & Triptorelin | — | — | — | — | — | 1 | |
| ADT + Nilutamide, Flutamide, & Bicalutamide | — | — | — | — | — | 1 | |
| Degarelix & Relugolix | — | — | — | — | — | 1 | |
| ADT + Docetaxel +/- prednisone | — | — | — | — | — | 1 | |
| ADT + Abiraterone + Prednisone | — | — | — | — | — | 1 |
76 more active programs hidden
Next readouts
- 2024-11-30
- 2025-06-30
- 2025-12-31
- 2026-01-01
- 2026-02-02
- 2026-04-30
- 2026-05-01
- 2026-05-31
- 2026-06-30
- 2026-07-06
Top conditions
- Stroke74
- PTSD69
- Depression62
- Posttraumatic Stress Disorder56
- Obesity46
- Spinal Cord Injury44
- Schizophrenia43
- Stress Disorders, Post-Traumatic36
Frequently asked questions about VA Office of Research and Development
- How many clinical trials does VA Office of Research and Development have on ClinicalTrials.gov?
- VA Office of Research and Development is listed as the lead sponsor on 1,720 clinical trials in ClinicalTrials.gov, 463 of which are currently active (recruiting, enrolling, or ongoing).
- How many of VA Office of Research and Development's trials are in Phase 3?
- 83 of VA Office of Research and Development's trials are in Phase 3, spread across 116 active drug programs.
- What therapeutic areas does VA Office of Research and Development focus on?
- VA Office of Research and Development's most-studied conditions on ClinicalTrials.gov are Stroke, PTSD, Depression, Posttraumatic Stress Disorder, Obesity.
- When are VA Office of Research and Development's next clinical trial readouts?
- VA Office of Research and Development has 10 upcoming primary-completion readouts tracked here; the soonest is “A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee”, expected around 2024-11-30.